The aim of the VOGAS project has been to carry out the clinical approbation of the latest generation stationary breath analyzer for the early diagnosis of cancer and to clarify the sources of volatile markers. Using the latest generation stationary breath analyzer for determination of volatile markers, the project participants performed breath analyzes in clinical settings, evaluating the device’s usability and accuracy, as well as perfecting this non-invasive cancer detection method.
VOGAS partners share their thoughts on the main challenges faced during the last 3 years. From unforeseen challenges like the COVID-19 pandemic and the conflict in Ukraine to predicted risks as technical and logistical issues – the interviews are available on the project website www.vogas.eu
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986
LU konference